DXC006

· Hangzhou DAC Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DXC006, covering 2025-01-28 to 2025-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies [Phase 1]